+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotransmitter"

Cholinergic Drugs Market Report 2026 - Product Thumbnail Image

Cholinergic Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Anticholinergic Drugs Market Report 2026 - Product Thumbnail Image

Anticholinergic Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Fragile X Syndrome (FXS) Treatment Market Report 2026 - Product Thumbnail Image

Fragile X Syndrome (FXS) Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lewy Body Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Lewy Body Disease - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 80 Pages
  • Global
From
Diabetic Neuropathy - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathy - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 180 Pages
  • Global
From
From
Dementia Associated With Alzheimer'S Disease - Pipeline Insight, 2026 - Product Thumbnail Image

Dementia Associated With Alzheimer'S Disease - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 280 Pages
  • Global
From
Diabetic Neuropathic Pain - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Spinocerebellar Ataxias - Pipeline Insight, 2026 - Product Thumbnail Image

Spinocerebellar Ataxias - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
From
From
From
From
Lewy Body Disease Pipeline Analysis Report 2026 - Product Thumbnail Image

Lewy Body Disease Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Memory Disorders Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Memory Disorders Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain. The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more